What is DocPlanner?
Established in 2010 and headquartered in Warsaw, Poland, DocPlanner.com is a leading developer of appointment booking and management software tailored for healthcare providers. The platform streamlines patient-doctor interactions, offering a comprehensive solution for scheduling, communication, and practice management. DocPlanner's innovative approach has positioned it as a critical technology enabler within the healthcare ecosystem, facilitating digital transformation for medical professionals and improving patient access to care across its operational regions.
How much funding has DocPlanner raised?
DocPlanner has raised a total of $140.4M across 6 funding rounds:
Other Financing Round
$1M
Series A
$3M
Series B
$10M
Series C
$20M
Series D
$16.8M
Other Financing Round
$89.6M
Other Financing Round (2012): $1M with participation from Piton Capital and RTAventures VC
Series A (2013): $3M led by Piton Capital and RTAventures VC
Series B (2015): $10M supported by Piton Capital, RTAventures, and Point Nine
Series C (2016): $20M featuring EBRD and Target Global
Series D (2017): $16.8M backed by Enern Investments, One Peak Partners, and Target Global
Other Financing Round (2019): $89.6M with participation from Piton Capital, One Peak Partners, Goldman Sachs Private Capital Investing, and ENERN Investments
Key Investors in DocPlanner
One Peak Partners
One Peak Partners is a growth equity firm that invests in technology companies during their scale-up phase, providing capital to transform rapidly growing businesses into category leaders. Their portfolio includes various tech companies, indicating a focus on scalable and innovative ventures.
Target Global
Target Global is a pan-European technology investment firm managing significant assets and investing across all stages of a company's lifecycle. They have a broad portfolio of successful tech investments, demonstrating expertise in identifying and nurturing high-growth potential companies.
Goldman Sachs Private Capital Investing
Goldman Sachs is a global investment banking and financial services firm. Its Private Capital Investing arm focuses on providing strategic capital to companies, leveraging its extensive financial expertise and market reach to support growth and development.
What's next for DocPlanner?
With its recent major strategic investment, DocPlanner is poised for accelerated growth and further market penetration. The company's consistent access to significant capital, including a Series D round, suggests a mature stage of development, likely focused on scaling operations, enhancing its technological offerings, and potentially exploring new geographic markets or service verticals. This strategic financing will undoubtedly empower DocPlanner to solidify its leadership position in the competitive health-tech landscape and continue its mission to improve healthcare accessibility through technology.
See full DocPlanner company page
